Non-Demented Individuals with Alzheimer’s Disease Neuropathology: Resistance to Cognitive Decline May Reveal New Treatment Strategies

Author(s): Olga Zolochevska, Giulio Taglialatela

Journal Name: Current Pharmaceutical Design

Volume 22 , Issue 26 , 2016

Become EABM
Become Reviewer
Call for Editor


Alzheimer’s disease (AD) is a terminal neurodegenerative disorder that is characterized by accumulation of amyloid plaques and neurofibrillary tangles in the central nervous system. However, certain individuals remain cognitively intact despite manifestation of substantial plaques and tangles consistent with what would be normally associated with fully symptomatic AD. Mechanisms that allow these subjects to escape dementia remain unresolved and understanding such protective biological processes could reveal novel targets for the development of effective treatments for AD. In this review article we discuss potential compensatory mechanisms that allow these individuals to remain cognitively intact despite the typical AD neuropathology.

Keywords: Alzheimer’s disease, Non-Demented with Alzheimer’s Neuropathology, compensatory mechanisms in AD, resistance to cognitive decline.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 18 May, 2016
Page: [4063 - 4068]
Pages: 6
DOI: 10.2174/1381612822666160518142110
Price: $65

Article Metrics

PDF: 33